XSpray Pharma AB Cash Flow Reinvestment Rate
Latest as of September 2017:
138.93x
XSpray Pharma AB cash flow reinvestment rate. XSpray Pharma AB (XSPRAY) has a Cash Flow Reinvestment Rate of 138.93x as of September 2017, reinvesting Skr6.39 Million (capex Skr6.39 Million ) from operating cash flow of Skr46.00K. Explore XSpray Pharma AB cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
138.93x
(Capex + Investments) / Operating CF
Total Reinvested
Skr6.39 Million
Capex + Investments
Operating Cash Flow
Skr46.00K
SEK
Capital Expenditures
Skr6.39 Million
SEK
XSpray Pharma AB Cash Flow Reinvestment Rate by Year (None–None)
XSpray Pharma AB cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for XSpray Pharma AB. For the full cash flow conversion analysis, see XSPRAY cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow